Then, the clinical significance of the overexpressed genes associated with the BC cell susceptibility to CD32-CR T cells was assessed by using a clinically well-documented TCGA advanced BC-RNA-seq database R2: Genomics Analysis and Visualization Platform (http://r2.amc.nl). This evidence concerns the gene FCGR2C and breast cancer.